Satellos Bioscience Inc. (MSLE) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-21.5%

$5.02

vs $6.40 price

Levered DCF

$5.77

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-1.71

Distress zone

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.35×	-4.71×	-5.75×	-2.52×	-1.49×	-8.44×	-2.36×	-2×
P/B	0.31×	2.06×	1.66×	8.55×	2.18×	-72.49×	6.9×	-5.46×
P/S	0×	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	0.05×	-2.92×	-3.84×	-3.28×	-2.99×	-8.54×	-1.62×	-1.55×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	7.77×	14.16×	11.13×	0.79×	2.59×	5.13×	1.81×	0.22×
Debt / equity	0×	0×	0×	0×	0×	-5.95×	0×	0×
Interest coverage	0×	0×	-87.36×	0×	-8.6×	-5,557.29×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-89.5%	-41.4%	-29.4%	-339.5%	-188.6%	856.7%	-293.4%	272.6%
Return on invested capital	-95.2%	-41.0%	-28.7%	-252.6%	-80.9%	-304.2%	-293.7%	352.6%
Return on assets	-78.0%	-38.5%	-27.0%	-184.5%	-157.1%	-139.4%	-132.0%	-955.6%
Free cash flow yield	-274.1%	-17.9%	-21.4%	-15.0%	-22.0%	-12.5%	-49.2%	-32.5%
Earnings yield	-288.8%	-20.1%	-17.7%	-39.7%	-86.4%	-11.8%	-42.5%	-49.9%
Enterprise value	-$1.2M	$57.2M	$45.4M	$26.6M	$14.1M	$13.7M	$3.7M	$3.4M
Net debt / EBITDA	0.37×	2.05×	1.86×	0.23×	0.81×	-0.24×	0.45×	0×
Cash conversion cycle (days)	-127,144	-37,768	-71,874	-142	-1,936	0	0	0